LABCA & GEICAM: Molecular Tumor Board for Breast Cancer – April 14th

The landscape of cancer treatment is constantly evolving, and a significant collaboration between Latin American and European medical institutions is poised to bring cutting-edge insights to the forefront. On April 14th, a special edition of the Molecular Tumor Board (MTB) – a joint initiative between LABCA (Latin American Breast Cancer Association) and GEICAM (Spanish Breast Cancer Group) – will convene, offering a unique opportunity for specialists to discuss complex clinical cases and advance the field of breast oncology. For residents of Austin, Texas, a city rapidly becoming a hub for medical innovation and healthcare technology, this international exchange highlights the growing importance of collaborative, data-driven approaches to cancer care.

The MTB isn’t simply a conference; it’s a multidisciplinary forum designed to foster a deeper understanding of breast cancer through the analysis of individual patient cases. Specialists from across Latin America and Europe will participate, sharing their expertise in clinical experience, genetic counseling, and various medical disciplines. This collaborative spirit is particularly relevant in a diverse city like Austin, where healthcare providers serve a broad patient population with varying genetic backgrounds and healthcare needs. The focus on evidence-based discussion and clinical decision-making aligns with the principles championed by institutions like the Dell Medical School at the University of Texas at Austin, which is actively working to transform healthcare delivery through research and innovation.

A Global Dialogue in Clinical Oncology

The LABCA–GEICAM MTB represents a crucial bridge between continents, facilitating the exchange of knowledge and best practices in breast cancer treatment. This is especially important given the disparities in access to advanced diagnostics and therapies that can exist between different regions. The initiative aims to enrich therapeutic approaches by integrating clinical experience, genetic insights, and a multidisciplinary perspective. Here in Austin, a city known for its vibrant tech sector, the emphasis on data-driven insights resonates strongly. Companies like Flatiron Health, with a significant presence in the area, are dedicated to leveraging real-world data to improve cancer care, mirroring the MTB’s commitment to evidence-based medicine.

This particular session will feature a compelling case presentation by Dr. William Mantilla from Colombia, alongside genetic counseling insights from Dr. Alejandro Ruiz, also from Colombia. Adding further weight to the discussion is the participation of Dr. Ángel Guerrero Zotano from Spain, serving as a special guest. The inclusion of experts from multiple countries underscores the global nature of cancer research and the necessitate for international collaboration. Austin’s own St. David’s HealthCare system, a major provider in the region, actively participates in national and international clinical trials, demonstrating a similar commitment to advancing medical knowledge.

Date and Times

📅 Tuesday, April 14th
🕒 16:00 h CET (Madrid – Berlin)

Timings for Latin America:

• Argentina / Brazil: 11:00 h
• Venezuela: 10:00 h
• Colombia / Perú / Ecuador / Panamá: 09:00 h
• Guatemala / México: 08:00 h

💻 Virtual modality

Continuing Medical Education and International Cooperation

The partnership between LABCA and GEICAM underscores a shared dedication to continuing medical education, scientific exchange, and strengthening professional networks dedicated to improving breast cancer care globally. This commitment is particularly vital in a rapidly evolving field like oncology, where new discoveries and treatment modalities are constantly emerging. In Austin, organizations like the American Cancer Society – Southwest Region, actively promote continuing education opportunities for healthcare professionals, aligning with the MTB’s mission. The collaborative spirit fostered by LABCA and GEICAM mirrors the innovative partnerships being forged within Austin’s burgeoning healthcare ecosystem.

The event is accessible virtually, making it easier for professionals worldwide to participate. This accessibility is crucial for disseminating knowledge and ensuring that the latest advancements in breast cancer treatment reach a wider audience. The virtual format also reflects the growing trend towards telehealth and remote medical education, a trend that is gaining traction in Austin and across the United States.

* The room will be enabled approximately half an hour before the start